NEW YORK, NY / ACCESSWIRE / January 26, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
Minerva Neurosciences, Inc. (NASDAQ:NERV)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/minerva-neurosciences-inc-loss-submission-form?prid=12443&wire=1
Lead Plaintiff Deadline: February 8, 2021
Class Period: May 15, 2017 - November 30, 2020
Allegations against NERV include that: (i) the truth about the feedback received from the FDA concerning the "end-of-Phase 2" meeting; (ii) the Phase 2b study did not use the commercial formulation of roluperidone and was conducted solely outside of the United States; (iii) the failure of the Phase 3 study to meet its primary and key secondary endpoints rendered that study incapable of supporting substantial evidence of effectiveness; (iv) the Company's plan to use the combination of the Phase 2b and Phase 3 studies would be "highly unlikely" to support the submission of an NDA; (v) reliance on these two trials in the submission of an NDA would lead to "substantial review issues" because the trials were inadequate and not well-controlled; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.
Qiwi plc (NASDAQ:QIWI)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/qiwi-plc-loss-submission-form?prid=12443&wire=1
Lead Plaintiff Deadline: February 9, 2021
Class Period: March 28, 2019 - December 9, 2020
Allegations against QIWI include that: (1) Qiwi's internal controls related to reporting and record-keeping were ineffective; (2) consequently, the Central Bank of Russia would impose a monetary fine upon the Company and impose restrictions upon the Company's ability to make payments to foreign merchants and transfer money to pre-paid cards; and (3) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.
Triterras, Inc., f/k/a Netfin Acquisition Corp. (NASDAQ:TRIT)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/triterras-inc-f-k-a-netfin-acquisition-corp-loss-submission-form?prid=12443&wire=1
Lead Plaintiff Deadline: February 19, 2021
Class Period: August 20, 2020 - December 16, 2020
Allegations against TRIT include that: (1) the extent to which Company's revenue growth relied on Triterras' relationship with Rhodium to refer users to the Kratos platform; (2) that Rhodium faced significant financial liabilities that jeopardized its ability to continue as a going concern; (3) that, as a result, Rhodium was likely to refer fewer users to the Company's Kratos platform; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]
SOURCE: The Law Offices of Vincent Wong